A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants with Open-Angle Glaucoma or Ocular Hypertension

Investigation of a Topical Treatment for Glaucoma

Recruiting
18 years - 100 years
All
Phase 3
1 participants needed
1 Location

Brief description of study.

Glaucoma treatment study

Detailed description of study

This study is evaluating the duration and safety of a topical medication (Bimatoprost SR) for people who have OAG or OHT.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: OAG,eyes,eye,glaucoma,open-angle glaucoma,ocular hypertension,OHT,POAG,vision
  • Age: 18 years - 100 years
  • Gender: All

Eligibility Criteria
Diagnosis of either OAG (ie, primary OAG, pseudoexfoliation glaucoma,
pigmentary glaucoma) or OHT in the study eye, requiring IOP-lowering treatment
 
Exclusion Criteria
Previous glaucoma eye surgery

Updated on 19 Feb 2024. Study ID: 1904606314

This study investigates the effectiveness and safety of a topical medication for individuals with open-angle glaucoma (OAG) or ocular hypertension (OHT). Open-angle glaucoma is a condition where the drainage angle for eye fluid remains open, but the fluid doesn't flow out as it should, increasing eye pressure. Ocular hypertension refers to higher than normal eye pressure without any optic nerve damage.

Participants in the study will receive a topical medication applied to the eye. The study will assess how long the medication lasts and its safety profile. No previous glaucoma surgeries are allowed for participants.

  • Who can participate: Adults diagnosed with open-angle glaucoma or ocular hypertension in at least one eye are eligible to participate. Participants must require treatment to lower intraocular pressure and must not have had previous glaucoma eye surgery.
  • Study details: Participants will apply a topical medication to their eye as part of the study. The study will evaluate how long the medication remains effective and monitor its safety. An inactive substance that looks like the investigational medication but does not contain any medicine may be used as a comparison.

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Race
Ethnicity
Other language

Default Content Message Here